Crossmark

Nanoparticles-based biosensor devices developed for point-of-care (POC) analyses of c-reactive protein (CRP) as the clinically important inflammatory biomarker

Crossref DOI link: https://doi.org/10.1007/s11696-024-03810-x

Published Online: 2024-11-18

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karami, Pari

Afsar, Taha

Gholamin, Danial

Pahlavan, Yasamin

Johari-Ahar, Mohammad https://orcid.org/0000-0003-2867-4261
Funding

Funding for this research was provided by:

Ardabil University of Medical Sciences (402000640)
License Information

Text and Data Mining valid from 2024-11-18

Version of Record valid from 2024-11-18
More Information

Article History

Received: 29 August 2024

Accepted: 9 November 2024

First Online: 18 November 2024

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors also declare that they have not used AI tools to analyze and draw insights from data as part of the research process.

Document is current

Any future updates will be listed below